Polar Asset Management Partners’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-186,700	Closed	-$330K	–	857
2023 Q4	$330K	Buy	+186,700	New	+$330K	0.01%	449